CHICAGO, Jan. 13, 2014 /PRNewswire/ -- Analyte Health (http://www.analytehealth.com) announced today that Lawrence Leisure has joined its Advisory Board. Mr. Leisure comes with a wealth of experience within the health and managed care industries, and currently serves as a Life Sciences partner at Kleiner Perkins Caufield & Byers. He has held consulting leadership positions at Ingenix Consulting where he led their Payer & Employer Market Group, Accenture where he was the Global Managing Partner for the Health Vertical, and Towers Perrin where he led the Managed Care practice. In these various roles he also served as client partner to many of the largest US health plans and pharmacy benefit management organizations as well as a number of the largest global employers.
Mr. Leisure joins the Analyte Health Advisory Board and will be involved in providing strategic insights for new channel development, medical ecosystem partnerships, and the continued expansion of the company's Diagnostic Triage platform to other health conditions. "I have been invested in the acceleration of innovation in health care for many years. Analyte Health is positioned to be a leader in diagnostic triage and I am excited to work with the team to further develop its reach and impact," said Mr. Leisure.
Sridhar Murthy, CEO of Analyte Health said, "We are excited to welcome Lawrence Leisure to our Advisory Board. His wealth of experience and industry knowledge will provide an invaluable resource as we find new and effective ways to effectively and efficiently diagnose diseases early, and to triage these patients quickly to the appropriate care."
About Analyte Health, Inc.
Analyte Health is a diagnostic triage company. Its mission is to provide convenient access to education, diagnostic testing, personalized results and recommendations to consumers through its Online Clinics. Analyte Health offers access to healthcare via the phone and the web to a national team of doctors and partner diagnostic labs. Over 125,000 patients have trusted Analyte Health to deliver convenient and private STD testing and care. More information about the company is available at http://www.AnalyteHealth.com.
Analyte Health, Inc. is a privately held company. This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits to consumers from using Analyte Health's services. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due to a variety of risks and uncertainties, including, among other things, the potential impact of regulatory and third party payer developments in the field of telehealth and STD testing, general business and economic conditions, changes in arrangements with vendors or suppliers, and costs or delays in obtaining or maintaining regulatory approvals and licenses. Any forward-looking statements in this release are based on limited information currently available to Analyte Health, which is subject to change, and Analyte Health will not necessarily update the information.
SOURCE Analyte Health, Inc.